1-6 of 6
Levi D. Pederson
Close
Sort by
Journal Articles

Outcomes in Mantle Cell Lymphoma with Central Nervous System Involvement - a Dual Center Study

Nicole McLaughlin, Ashlee Joseph, Yucai Wang, Levi D. Pederson, Susan M. Geyer, Thomas E. Witzig, Andrew D. Zelenetz, J. C. C Villasboas, Michael Scordo, Paul A. Hamlin, N. Nora Bennani, Ariela Noy, Gita Thanarajasingam, Grzegorz S. Nowakowski, Luis Porrata, Carrie Thompson, Ivana Micallef, Patrick B Johnston, Thomas M. Habermann, Stephen M Ansell, Anita Kumar, Jonas Paludo
Journal: Blood
Blood (2023) 142 (Supplement 1): 1670.
https://doi.org/10.1182/blood-2023-174701
Published: 2023
Journal Articles

PD-1 Blockade before Autologous Stem Cell Transplantation Improves Outcomes in Relapsed/Refractory Classic Hodgkin Lymphoma: Results from a Multicenter Cohort

Sanjal H. Desai, Reid W. Merryman, Harsh Shah, Levi D. Pederson, Susan M. Geyer, Nivetha Ganesan, Tiffany Chang, Tamer Othman, Ayo S Falade, Gunjan L. Shah, Urshila Durani, Kelsey Baron, Shin Yeu Ong, Steve M Ansell, Philippe Armand, Siddharth Iyengar, Ivana Micallef, Alison Moskowitz, Alex F. Herrera, Robert Stuver, Matthew Genyeh Mei
Journal: Blood
Blood (2023) 142 (Supplement 1): 182.
https://doi.org/10.1182/blood-2023-179573
Published: 2023
Journal Articles

PET2 Response Associated with Survival in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Results of Two Independent Prospective Cohorts

Sanjal H Desai, Levi D. Pederson, Betsy Laplant, Raphael Mwangi, Matthew J. Maurer, Jason R. Young, William R. Macon, Rebecca L. King, Yucai Wang, James R. Cerhan, Andrew L. Feldman, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski
Journal: Blood
Blood (2021) 138 (Supplement 1): 2508.
https://doi.org/10.1182/blood-2021-151276
Published: 2021
Journal Articles

Local Review Versus (vs) Central Review of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Diffuse Large B-Cell Lymphoma (DLBCL): Results from the CALGB 50303 Trial [Alliance]

Amy S. Ruppert, PhD, Levi D. Pederson, MS, Michael V. Knopp, MD PhD, David Poon, BS, Jun Zhang, PhD, Brad S. Kahl, MD, Jonathan W. Friedberg, MD MSSc, Lawrence H. Schwartz, MD, Wyndham H. Wilson, MD PhD, John P. Leonard, MD, Nancy L. Bartlett, MD, Heiko Schöder, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 50.
https://doi.org/10.1182/blood-2020-139979
Published: 2020
Journal Articles

A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

N. Nora Bennani, MD, Levi D Pederson, Pamela Atherton, Ivana Micallef, MD, Joseph P. Colgan, MD, Gita Thanarajasingam, MD, Grzegorz Nowakowski, MD, Thomas E. Witzig, MD, Andrew L. Feldman, MD, Stephen M Ansell, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 467.
https://doi.org/10.1182/blood-2019-126194
Published: 2019
Journal Articles

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma

Clinical Trials & Observations
Han W. Tun, Patrick B. Johnston, Lisa M. DeAngelis, Pamela J. Atherton, Levi D. Pederson, Patricia A. Koenig, Craig B. Reeder, Antonio M. Padula Omuro, David Schiff, Brian O’Neill, Jose Pulido, Kurt A. Jaeckle, Christian Grommes, Thomas E. Witzig
Journal: Blood
Blood (2018) 132 (21): 2240–2248.
https://doi.org/10.1182/blood-2018-02-835496
Published: 2018
Includes: Supplemental data